Warning from FDA: Misleading Claims on Dietary Supplement
The Food and Drug Administration (FDA) has recently raised concerns about the identification label of a dietary supplement called Optimors VC-1. The label contains misleading claims that may deceive consumers regarding the product’s benefits for eye health.
According to the label, Optimors VC-1 supposedly prevents blurred vision and provides relief for dry eyes, particularly among elderly individuals. It also states that the supplement has been researched by Professor Dr. Pornanong Aramwit from Chulalongkorn University Faculty of Pharmacy.
However, the head of the research project has stated in a letter that the study solely involved tests conducted on cultured cells. It explicitly states that there have been no clinical trials performed on humans. Consequently, advertising these findings as the actual benefits of the product is both inappropriate and misleading.
The FDA firmly emphasizes that such deceptive advertising regarding the qualities and benefits of food products is a violation of the Food Act BE 2522 (1979). In response, the organization has vowed to take legal action against those found guilty of this offense.
The FDA urges consumers to remain vigilant and avoid being misled by such claims. It is essential to exercise caution when purchasing dietary supplements and not to rely solely on advertisements that may exaggerate the benefits or quality of these products.
For further information or concerns regarding misleading dietary supplement claims, individuals are encouraged to reach out to the FDA directly.
Food and Drug Administration (FDA) note that dietary supplementsIdentification label Optimors VC-1 which shows the message “No blurred eyes, no more blurred vision Research VC-1 by Chulalongkorn University Faculty of Pharmacy by Professor Dr. Pornanong Aramwit” and “Elderly people, dry eyes, blurred vision, VC-1, moist eyes, poor eyesight”
But the head of the research project has a letter stating that “This research is only a test in cultured cells. “Does not include clinical testing in humans” is an unreasonable false advertisement of the benefits and quality of food. The FDA will take legal action against those who violate the Food Act BE 2522 (1979).
The FDA warns that such products It is an advertisement of benefits. Fake quality or properties of food, don’t be fooled.
#FDA #warns #dietary #supplements #Sold #online #popular #apps #Pretending #false #credentials
